Scinovex
Subscribe
S

Stephen L. Chan

Chinese University of Hong Kong (HK)ORCID 0000-0001-8998-5480
h-index
84
Publications
721
Citations
36.2K
i10-index
256
Impact (2-yr)
16.35
Citations per year
Research Areas
Hepatocellular Carcinoma Treatment and PrognosisCancer Immunotherapy and BiomarkersCholangiocarcinoma and Gallbladder Cancer StudiesPancreatic and Hepatic Oncology ResearchLiver Disease Diagnosis and Treatment
Affiliations
James S. McDonnell Foundation
US · 1988–1988
University of London
GB · 2016–2017
Western University
CA · 2012–2012
University College Hospital
GB · 2018–2018
Hospital Authority
HK · 2024–2024
St George's Hospital
GB · 1998–2005
Nanjing University of Chinese Medicine
CN · 2023–2023
Department of Health
CN · 1994–1994

Top Publications

Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
Journal of Clinical Oncology20142,678 citations
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
The Lancet Oncology20182,498 citations
Clinical spectrum of cutaneous adverse drug reactions (ADR) and to determine the causative drugs
International Journal of Dermatology Venereology and Leprosy Sciences20190 citationsFirst authorCorresponding
Stephen L. Chan · Scinovex